Morning Briefing
Summaries of health policy coverage from major news organizations
Perspectives: What If Single-Payer Could Actually Boost Fortunes For The Middle Class?; GOP Gets Credit For Popularity Of The Health Law
As the national debate about health care kicks off ahead of the 2020 presidential election, we鈥檙e going to be hearing a lot about the costs of increasingly popular progressive proposals to provide universal health care, like Bernie Sanders鈥檚 Medicare for All plan. One common refrain on the right and the center-left alike: Since the rich can鈥檛 foot the bill alone, are middle- and working-class supporters of a more socialized health care system really ready to pay as much for it as people do in some of the high-tax nations that have one? The problem is, we already do, and we often pay more. (Matt Bruenig, 4/29)
ObamaCare is finally popular with the American people according to a variety of polls, and it鈥檚 instructive to understand why. The doing is Donald Trump鈥檚 and the Republicans鈥�, and not in a way that made ObamaCare a sensible program. Thanks to their effective repeal of the individual mandate, nobody is forced any longer to buy ObamaCare or pay a tax penalty. ObamaCare鈥檚 user cohort now consists almost entirely of willing 鈥渂uyers鈥� who receive their coverage entirely or largely at taxpayer expense. It also consists of certain users who take advantage of the coverage for pre-existing conditions and stop paying once their condition has been treated. (Holman W. Jenkins, Jr., 4/26)
Often, the most effective way to make a point is to tell a story. And that鈥檚 what NPR does in its new report on high-deductible health policies (HDHPs) that are keeping too many Americans out of their doctors鈥� offices.聽Susan, who carries a gene that makes her predisposed to breast cancer, has one of those policies. The deductible of $6,000 meant that when she got her first MRI and a mammogram to screen for breast cancer, she paid $3,800 out of her own pocket. It cost so much in 2017 that she was forced to delay her screening in 2018. (David Balat, 4/27)